Recent research backs this up, showing higher gastroparesis rates in people who use semaglutide compared to other weight loss methods
Initial investigations may include complete blood count, metabolic panel, thyroid function tests, hemoglobin A1c, ESR/CRP, HIV testing, and urinalysis when clinically indicated
Wegovy, Zepbound, and any other branded pharmaceutical names referenced in this article are registered trademarks of their respective manufacturers and are not affiliated with, sponsored by, or equivalent to the compounded medications discussed here
Animal model studies suggest that liraglutide significantly inhibits liver cancer occurrence in diabetic mouse models, and this inhibitory effect may be partly attributed to its ability to improve the high-glucose microenvironment [44]